Intra-Cellular Therapies, Inc. Financial Ratios — ITCI Stock

Profitability (USD)

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	- -	-139.74	-36.2	-34.07	-26.67	-22.73	-37.44	-48.56	-46.88	-47.07	-41.18	-18.84	-7.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	100	100	- -	- -	91.59	90.17	91.79	92.7	91.63
EBITDA Margin (%)	-524.56	- -	-958.84	-5,654.55	-344,676.51	-35,700.42	-41,645.65	- -	- -	-1,023.92	-348.99	-105.55	-34.37	-17.08
Operating Margin (%)	-526.09	- -	-959.69	-5,659.2	-345,131.92	-35,759.96	-41,732.65	- -	- -	-1,026.27	-349.65	-105.82	-34.48	-17.15
Incremental Operating Margin (%)	- -	-526.09	- -	- -	- -	- -	- -	24,273.19	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-531.04	- -	-981.01	-5,604.98	-341,797	-34,883.55	-40,203.17	- -	- -	-1,007.47	-347.73	-102.86	-30.08	-10.9
Profit Margin (%)	-532.1	- -	-981.67	-5,605.28	-341,802.21	-35,205.79	-39,771.64	- -	- -	-1,007.53	-347.73	-102.86	-30.22	-10.97
Net Income to Common Margin (%)	-532.1	- -	-981.67	-5,605.28	-341,802.21	-35,205.79	-39,771.64	- -	- -	-1,007.53	-347.73	-102.86	-30.22	-10.97
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	23	29	25	20	17	17
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	6	7	5	4	4
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	20	24	19	15	13	13
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.15	-0.13	-0.09	-0.08	-0.11	-0.15
Net Debt/EBITDA	1.17	- -	1.34	1.98	0.45	0.41	0.37	0.34	0.7	0.26	0.32	0.57	0.93	2.64
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.15	-0.13	-0.09	-0.08	-0.11	-0.15
Net Debt/EBIT	1.17	- -	1.34	1.98	0.45	0.41	0.37	0.34	0.7	0.26	0.32	0.56	0.93	2.63
EBITDA to Interest Expense	-84.53	- -	-42.81	-4,377.38	- -	-3,209.86	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-84.73	- -	-42.87	-4,379.05	- -	-3,211.2	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-84.77	- -	-42.85	-4,380.99	- -	-3,215.22	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-154.84	-776.41	-149.71	-67.31	-39.88	-79.58	-86.37	-157.44	-282.7	-130.64	-249.27	-195.75	-222.05	-123.77
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	10.23	3.59	4.47	2.36	2.25	1.11
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.9	-2.6	-1.56	-1.06	-0.83	-0.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	7.94	3.29	3.81	2.05	1.83	0.93
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.87	4.44	6.08	3.05	2.86	1.48
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-3.37	-3.21	-2.12	-1.38	-1.06	-1.01
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	9.21	4.06	5.19	2.66	2.33	1.24
Net Debt to Equity	-112.73	18.42	-111.18	-50.87	-9.9	-12.95	-8.32	-17.29	-55.2	-9.14	-22.1	-22.65	-24.98	-26.73
Net Debt/Capital (%)	38.41	11.41	37.91	41	19.63	13.58	8.49	8.9	13.55	6.2	7.17	9.25	8.45	15.49
EBITDA	-16	- -	-26	-31	-106	-118	-102	-162	-154	-231	-285	-263	-159	-116
EBITDA-CapEx	-16	- -	-26	-31	-107	-118	-103	-162	-154	-231	-285	-264	-159	-117
Operating Income (Loss)	-16	- -	-26	-31	-106	-118	-103	-162	-154	-231	-286	-264	-159	-117

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	6.74	0.16	5.44	12.28	75.87	36.47	32.68	9.57	6.18	17.84	7.73	7.11	4.03	4.87
Current Ratio	6.91	0.16	5.6	12.41	77.15	36.86	33.02	9.79	6.36	18.75	8.76	8.87	5.41	6.36
Quick Ratio	6.85	0.16	5.49	12.29	75.87	36.48	32.68	9.57	6.18	18.13	8.11	8.01	4.95	5.68
CFO/Avg Current Liab	- -	- -	-6.59	-2.62	-12.16	-10.87	-6.51	-4.68	-3.53	-6.3	-5.75	-3.96	-1.2	-0.44
Common Equity/Total Assets	-154.84	-776.41	-149.71	-67.31	-39.88	-79.58	-86.37	-157.44	-282.7	-130.64	-249.27	-195.75	-222.05	-123.77
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	10.23	3.59	4.47	2.36	2.25	1.11
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.9	-2.6	-1.56	-1.06	-0.83	-0.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	7.94	3.29	3.81	2.05	1.83	0.93
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.87	4.44	6.08	3.05	2.86	1.48
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-3.37	-3.21	-2.12	-1.38	-1.06	-1.01
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	9.21	4.06	5.19	2.66	2.33	1.24
CFO/Total Liabilities	-665.69	- -	-330.57	-216.04	-1,301.17	-680.98	-472.1	-299.23	-227.81	-380.58	-360.32	-273.72	-90.74	-33.5
CFO/CapEx	-485.23	- -	-679.33	-1,939.05	-118.85	-1,863.76	-111.26	-302.02	-182.73	-861.7	-798.6	-347.28	-461.71	-227.26
Altman's Z-Score	-3.72	-17.56	-3.3	28.12	148	28.26	22.76	6.84	15.17	20.44	31.19	27.73	27.8	23.11

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	16.28	2.82	0.75	5.29	5.21	- -	- -	4.19	5.29	5.23	4.89	4.85
Days Sales Outstanding	- -	- -	22.43	129.3	489.68	68.98	70.03	- -	- -	87.19	69.06	69.84	74.71	75.23
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.54	1.07	1.28	1.9	3
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	679.57	340.8	284.49	192.35	121.52
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.38	1.26	3.82	1.97	3.82
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	263.55	290.16	95.65	185.69	95.65
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	503.21	119.69	258.69	81.38	101.1
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-592.38	-271.73	-214.65	-117.64	-46.29
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	8	24	12	26
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	17	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	3	4	15
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	3	4	7	11
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	- -	506	1,940	652	669	623	1,893	2,238	4,253	4,977	6,867	8,614
- Cash & Cash Equivalents	19	- -	35	61	47	49	38	55	108	60	92	149	148	307
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	23	29	25	20	17	17
Enterprise Value	-19	- -	-37	376	1,465	268	204	276	1,693	1,609	3,866	4,405	6,386	7,629
Total Capital	-31	- -	-58	-88	-193	-309	-407	-562	-687	-908	-1,196	-1,457	-1,600	-1,675
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-3.37	-3.21	-2.12	-1.38	-1.06	-1.01
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.02	0.01	- -	- -	- -
EV/Sales	- -	- -	- -	686.75	47,782.51	811.59	831.38	- -	- -	71.43	47.31	17.68	13.82	11.21
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	506	1,940	652	669	623	1,893	2,238	4,253	4,977	6,867	8,614
Diluted Enterprise Value	-19	- -	-35	444	1,893	604	631	568	1,809	2,207	4,186	4,848	6,736	8,324
EV per Share	- -	- -	- -	13.12	40.62	6.21	4.43	5.04	30.67	22.87	47.58	46.84	66.6	73.98
TTM Sales	3	- -	3	1	- -	- -	- -	- -	- -	23	82	249	462	681
TTM EBITDA	-16	- -	-26	-31	-106	-118	-102	-162	-154	-231	-285	-263	-159	-116
TTM Operating Income	-16	- -	-26	-31	-106	-118	-103	-162	-154	-231	-286	-264	-159	-117
TTM Cash Flow to Firm	-19	- -	-22	-23	-102	-91	-80	-118	-128	-230	-260	-270	-124	-73
TTM Free Cash Flow to Firm	-19	- -	-22	-23	-101	-91	-80	-118	-127	-230	-259	-269	-124	-73

Multiples (USD)

API Chat

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	- -	-22.18	-19.13	-7.15	-8.38	-5.29	-14.88	-9.74	-16.41	-18.47	-55.41	-118.23
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-19	- -	-37	376	1,465	268	204	276	1,693	1,609	3,866	4,405	6,386	7,629
Low Price	- -	- -	- -	12.67	16.29	10.8	7.85	10.21	6.75	10.94	28.4	38.51	42.01	62.78
EV/Sales	- -	- -	- -	686.75	47,782.51	811.59	831.38	- -	- -	71.43	47.31	17.68	13.82	11.21
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-15.21	-11.31	-11.51	-6.63	-6.78	-4.4	-7.06	-10.62	-19.35	-38.87	-102.1
Price/Earnings High	- -	- -	- -	-19.85	-20.92	-20.56	-10.71	-9.11	-16.27	-10.64	-15.79	-24.22	-50.92	-129.06
Price/Earnings Low	- -	- -	- -	-11.83	-5.61	-4.01	-3.71	-3.6	-2.52	-3.39	-8.12	-14.13	-28.84	-86.7
Price/Book Value	- -	- -	- -	-5.73	-10.05	-2.11	-1.64	-1.11	-2.67	-2.39	-3.48	-3.37	-4.25	-5.09
Price/Book Value Average	- -	- -	- -	-5.29	-6.14	-4.33	-1.59	-1.87	-0.92	-1.71	-2.47	-3.36	-3.36	-4.51
Price/Book Value High	- -	- -	- -	-6.9	-11.36	-7.73	-2.57	-2.51	-3.39	-2.58	-3.67	-4.2	-4.4	-5.7
Price/Book Value Low	- -	- -	- -	-4.11	-3.04	-1.51	-0.89	-0.99	-0.52	-0.82	-1.89	-2.45	-2.49	-3.83
Price/Tangible Book Value	- -	- -	- -	4.19	4.07	1.74	1.47	1.96	9.71	3.41	10.18	7.59	11.61	7.5
Price/Tangible Book Value Average	- -	- -	- -	3.87	2.49	3.57	1.43	3.31	3.33	2.44	7.22	7.56	9.18	6.64
Price/Tangible Book Value High	- -	- -	- -	5.05	4.6	6.37	2.3	4.45	12.33	3.68	10.73	9.46	12.02	8.39
Price/Tangible Book Value Low	- -	- -	- -	3.01	1.23	1.24	0.8	1.76	1.91	1.17	5.52	5.52	6.81	5.64
Price/Sales	- -	- -	- -	923.53	63,282.05	1,973.06	2,720.15	- -	- -	99.31	52.05	19.98	14.86	12.66
Price/Sales Average	- -	- -	- -	852.67	38,651.96	4,052.36	2,638.13	- -	- -	71.15	36.93	19.91	11.75	11.2
Price/Sales High	- -	- -	- -	1,112.42	71,517.3	7,237.16	4,258.69	- -	- -	107.15	54.89	24.91	15.39	14.16
Price/Sales Low	- -	- -	- -	662.95	19,164.61	1,412.13	1,474.67	- -	- -	34.17	28.24	14.54	8.72	9.51
Price/Cash Flow	- -	- -	- -	-22.17	-18.97	-7.15	-8.31	-5.27	-14.79	-9.73	-16.39	-18.42	-55.29	-117.71
Price/Cash Flow Average	- -	- -	- -	-20.47	-11.59	-14.69	-8.06	-8.89	-5.08	-6.97	-11.63	-18.36	-43.71	-104.2
Price/Cash Flow High	- -	- -	- -	-26.71	-21.44	-26.23	-13.01	-11.95	-18.78	-10.49	-17.28	-22.97	-57.26	-131.7
Price/Cash Flow Low	- -	- -	- -	-15.92	-5.74	-5.12	-4.5	-4.73	-2.91	-3.35	-8.89	-13.4	-32.43	-88.48
Price/Free Cash Flow Average	- -	- -	- -	-20.48	-11.68	-14.69	-8.13	-8.92	-5.11	-6.98	-11.64	-18.41	-43.81	-104.66
Price/Free Cash Flow High	- -	- -	- -	-26.72	-21.62	-26.24	-13.12	-11.99	-18.89	-10.51	-17.3	-23.04	-57.38	-132.28
Price/Free Cash Flow Low	- -	- -	- -	-15.92	-5.79	-5.12	-4.54	-4.74	-2.93	-3.35	-8.9	-13.44	-32.5	-88.87
EV/Sales Average	- -	- -	- -	740.67	37,113.77	3,905.28	2,484.41	- -	- -	69.78	36.11	19.39	11.46	10.78
EV/Sales High	- -	- -	- -	1,000.42	69,979.11	7,090.08	4,104.97	- -	- -	105.78	54.07	24.4	15.1	13.74
EV/Sales Low	- -	- -	- -	550.95	17,626.43	1,265.04	1,320.95	- -	- -	32.79	27.42	14.02	8.43	9.09
EV/EBITDA Average	1.17	- -	1.34	-13.1	-10.77	-10.94	-5.97	-6.15	-3.68	-6.81	-10.35	-18.37	-33.35	-63.12
EV/EBITDA High	1.17	- -	1.34	-17.69	-20.3	-19.86	-9.86	-8.39	-15.11	-10.33	-15.49	-23.11	-43.94	-80.44
EV/EBITDA Low	1.17	- -	1.34	-9.74	-5.11	-3.54	-3.17	-3.11	-1.88	-3.2	-7.86	-13.28	-24.53	-53.22
EV/EBIT Average	1.17	- -	1.34	-13.09	-10.75	-10.92	-5.95	-6.14	-3.67	-6.8	-10.33	-18.32	-33.24	-62.84
EV/EBIT High	1.17	- -	1.34	-17.68	-20.28	-19.83	-9.84	-8.37	-15.06	-10.31	-15.47	-23.06	-43.8	-80.09
EV/EBIT Low	1.17	- -	1.34	-9.74	-5.11	-3.54	-3.17	-3.1	-1.87	-3.2	-7.84	-13.25	-24.45	-52.99
Last Price	- -	- -	- -	17.65	53.79	15.09	14.48	11.39	34.31	31.8	52.34	52.92	71.62	83.52
High Price	- -	- -	- -	21.26	60.79	55.35	22.67	25.82	43.56	34.31	55.2	66	74.17	93.45
Enterprise Value Average	-19	- -	-35	406	1,138	1,291	611	996	566	1,572	2,950	4,831	5,298	7,335
Enterprise Value High	-19	- -	-35	548	2,145	2,345	1,009	1,358	2,319	2,383	4,418	6,079	6,981	9,348
Enterprise Value Low	-19	- -	-35	302	540	418	325	504	288	739	2,241	3,493	3,897	6,185

	2012 Y	2013 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	22	22	22	29	43	43	55	55	56	80	82	95	96	106
Diluted Weighted Avg Shares	22	- -	17	29	36	43	46	55	55	70	81	94	96	103
Basic Weighted Avg Shares	22	- -	17	29	36	43	46	55	55	70	81	94	96	103
Revenue per Share	0.14	- -	0.16	0.02	- -	0.01	0.01	- -	- -	0.32	1.01	2.65	4.82	6.6
EBITDA per Share	-0.74	- -	-1.52	-1.08	-2.93	-2.73	-2.22	-2.96	-2.78	-3.28	-3.51	-2.8	-1.66	-1.13
Operating Income per Share	-0.74	- -	-1.52	-1.08	-2.93	-2.73	-2.22	-2.97	-2.79	-3.29	-3.52	-2.8	-1.66	-1.13
Basic EPS, GAAP	-0.75	- -	-1.56	-1.07	-2.91	-2.69	-2.12	-2.84	-2.68	-3.23	-3.5	-2.72	-1.46	-0.72
Basic EPS from Cont Ops	-0.75	- -	-1.56	-1.07	-2.91	-2.69	-2.12	-2.84	-2.68	-3.23	-3.5	-2.72	-1.46	-0.72
Diluted EPS, GAAP	-0.75	- -	-1.56	-1.07	-2.91	-2.69	-2.12	-2.84	-2.68	-3.23	-3.5	-2.72	-1.46	-0.72
Diluted EPS from Cont Ops	-0.75	- -	-1.56	-1.07	-2.91	-2.69	-2.12	-2.84	-2.68	-3.23	-3.5	-2.72	-1.46	-0.72
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.85	- -	-1.31	-0.8	-2.84	-2.11	-1.74	-2.16	-2.32	-3.27	-3.19	-2.87	-1.3	-0.71
Free Cash Flow per Basic Share	-0.85	- -	-1.31	-0.8	-2.86	-2.11	-1.76	-2.17	-2.33	-3.27	-3.2	-2.88	-1.3	-0.71
Cash & Equivalents per Share	0.86	- -	2.15	4.53	13.17	8.88	10.05	6.35	4.06	9.34	5.07	6.29	5.19	9.71
Book Value per Share	-1.39	- -	-3.33	-3.08	-5.35	-7.16	-8.82	-10.28	-12.87	-13.32	-15.03	-15.71	-16.87	-16.4
Tangible Book Value per Share	0.77	- -	1.83	4.21	13.2	8.68	9.84	5.81	3.53	9.34	5.14	6.98	6.17	11.14

Intra-Cellular Therapies, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)